发明名称 |
METHOD AND COMPOSITIONS FOR REDUCING CARDIAC DYSFUNCTIONS WITH A SELECTIVE HISTAMINE H3 RECEPTOR AGONIST |
摘要 |
The invention provides a method for reducing cardiac dysfunctions in a human. The method comprises administration to the human of an effective amount of a selective histamine H3 Receptor agonist. In one embodiment, the method comprises limiting the accumulation of intracellular sodium (Na1) by inhibiting the Na<+>/H<+> exchanger activity in the human having a cardiac dysfunction, or a predisposition to a cardiac dysfunction. In another embodiment the method comprises inhibiting the N-type Ca<2+> channel to modulate the concentration of intracellular calcium. The invention also provides a pharmaceutical composition that includes a selective histamine H3 Receptor agonist with a pharmaceutical carrier.
|
申请公布号 |
WO02064212(A1) |
申请公布日期 |
2002.08.22 |
申请号 |
WO2002US03452 |
申请日期 |
2002.02.08 |
申请人 |
CORNELL RESEARCH FOUNDATION, INC.;LEVI, ROBERTO;SILVER, RANDI, B. |
发明人 |
LEVI, ROBERTO;SILVER, RANDI, B. |
分类号 |
A61K31/00;A61K31/4164;A61K31/417;A61K31/4178;A61K31/454;A61K45/06;A61P9/00;A61P9/04;A61P9/08;A61P9/10;(IPC1-7):A61P9/00;A61K31/13;A61K31/132;A61K31/137 |
主分类号 |
A61K31/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|